Navigation Links
Vitamin D in Pregnancy May Be Key to Women's Risk for MS, Study Says
Date:11/19/2012

By Maureen Salamon
HealthDay Reporter

MONDAY, Nov. 19 (HealthDay News) -- Pregnant women with higher levels of vitamin D circulating in their blood were significantly less likely to develop multiple sclerosis in the years after giving birth, a new Swedish study suggests.

Researchers also found that vitamin D blood levels had decreased gradually since 1975 in those tested, possibly providing clues as to why MS has become more common in industrialized parts of the world.

"It seems that vitamin D might help twist the immune system towards a more non-inflammatory state, and this has been suggested as one of the [presumed] mechanisms by which vitamin D might influence MS risk," said study author Dr. Jonatan Salzer, a doctoral student in pharmacology and clinical neuroscience at Umea University. "The finding does, however, need confirmation in a different [group] before it's considered a 'true' finding, as is generally the case with these kinds of research results."

The study is published in the Nov. 20 online issue of the journal Neurology.

Thought to be an autoimmune disorder, MS affects about 400,000 people in the United States, according to the National MS Society. The disease attacks the fatty sheath protecting nerves in the central nervous system, causing disabling symptoms such as blurred vision, loss of balance, bladder and bowel difficulties, slurred speech, numbness and extreme fatigue.

Salzer and his team reviewed results from 291,500 blood samples collected from 164,000 people in the northern part of Sweden since 1975, including 124,000 samples from pregnant women. Women who had high blood levels of vitamin D were 61 percent less likely to develop MS compared to those with low levels.

However, no link was found between the mother's vitamin D levels and whether her child would later develop MS. These findings contradict a study published last week in the Journal of Neurology, Neu
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Vitamin E in diet protects against many cancers
2. Researchers determine vitamin D blood level for reducing major medical risks in older adults
3. Vitamin K2: New hope for Parkinsons patients?
4. Experts call for clinical trials to test non-skeletal benefits of vitamin D
5. Vitamin D + TB vaccine: Allies in fight against bladder cancer?
6. Vitamin C improves pulmonary function in newborns of pregnant smoking women
7. Vitamin C improves lung function in newborns of pregnant smoking women
8. Japanese-American Men With Low Vitamin-D Diet Face Higher Stroke Risk
9. Too much vitamin D can be as unhealthy as too little
10. Older adults may need more vitamin D to prevent mobility difficulties
11. Older Women Should Not Take Calcium, Vitamin D: Task Force
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Vitamin D in Pregnancy May Be Key to Women's Risk for MS, Study Says
(Date:12/25/2014)... Phoenix, AZ (PRWEB) December 25, 2014 ... comes to outstanding customer service and affordable quality regarding ... metropolitan area announces recognition in 2014 by the “Queen ... and Sons has earned an impressive reputation over the ... pricing on a wide range of contractor services for ...
(Date:12/24/2014)... Over 700 toys, that’s what AlignLife ... 700 smiling little faces this holiday that might not ... monetary donations was given to the various charities as ... incur through the year. Some of the charities chosen ... , Shrine's Children's Hospitals, Toys for Tots and Crisis ...
(Date:12/24/2014)... Connie Casad, MD, a well-known and respected gynecologist, ... years of practice experience in Dallas, Texas, has announced ... dietary detoxification. The second study is scheduled to begin ... test patients who just completed a 21-day detoxification regimen. ... conducting the study, Dr. Casad said, "About 10 years ...
(Date:12/24/2014)... 2014 Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) ... litigation currently underway in Pennsylvania’s Philadelphia Court of Common ... 24, 2014, court documents indicate that 1,183 claims had ... who developed gynecomastia (male breast growth) and other complications ... indicates that this represents an increase of more than ...
(Date:12/24/2014)... 2014 Dr. Vu Ho, a Dallas ... his practice and med-spa with the addition of new ... of cosmetic treatments and services. , “Silk Peel is ... says Dr. Ho. “As a result it can address ... sun spots, discolorations or blemishes.” , Similar to microdermabrasion, ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 3Health News:AlignLife Donates Over 700 Toys This Year 2Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 2Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2
... when malignancy is found early , , FRIDAY, Feb. ... Bader Ginsburg will face tough challenges following her surgery ... , At this point, it,s not clear exactly what ... suggest pancreatic adenocarcinoma, which accounts for about 85 percent ...
... Is No Champion of Corporate Governance,TUCSON, Ariz., Feb. 6 ... ) today commented on the recent announcement that an ... CITY) together with other related persons, including Donald E. ... Avalon, intends to initiate a consent solicitation against the ...
... PARK, Calif., Feb. 6 ROXRO announced today ... accepted for review the New Drug,Application (NDA) for ... management of acute moderate to severe pain.,ROX-888 is ... (NSAID), designed to provide ambulatory patients with a,convenient, ...
... Nu Skin Enterprises, Inc. (NYSE: NUS ) today announced ... quarterly cash dividend to $0.115 per share. Annually, this would ... The increase begins in the first quarter and will be ... 27, 2009. "Because of our financial stability and strong cash flow, ...
... 35% over same period in Fiscal 2008 -, ... dollars unless otherwise noted),BELLEVILLE, ON, Feb. 6 /PRNewswire-FirstCall/ ... research-based, technology-driven Canadian biopharmaceutical company, today announced financial ... fiscal year, ending December 31, 2008. , "We ...
... students with an in-depth licensed practical nursing career resource center to ... today,s thriving nursing industry. , ... Seattle, Washington (PRWEB) ... Nursing Career Resource Center offers comprehensive career and education information ...
Cached Medicine News:Health News:Supreme Court Justice Ginsburg Faces Tough Battle Against Pancreatic Cancer 2Health News:Supreme Court Justice Ginsburg Faces Tough Battle Against Pancreatic Cancer 3Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 2Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 3Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 4Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 5Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 6Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 7Health News:ROXRO Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain 2Health News:ROXRO Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain 3Health News:Nu Skin Enterprises Announces 5 Percent Increase in Quarterly Dividend 2Health News:Bioniche Reports Fiscal 2009 Second Quarter 2Health News:Bioniche Reports Fiscal 2009 Second Quarter 3Health News:Bioniche Reports Fiscal 2009 Second Quarter 4Health News:Bioniche Reports Fiscal 2009 Second Quarter 5Health News:Bioniche Reports Fiscal 2009 Second Quarter 6Health News:Bioniche Reports Fiscal 2009 Second Quarter 7Health News:Bioniche Reports Fiscal 2009 Second Quarter 8Health News:Bioniche Reports Fiscal 2009 Second Quarter 9Health News:Licensed Practical Nurse Career Resource Center Launches 2Health News:Licensed Practical Nurse Career Resource Center Launches 3
(Date:12/24/2014)... 24, 2014  Actavis plc (NYSE: ... received a complete response letter from the U.S. ... Drug Application (NDA) for the fixed-dose combination (FDC) ... hypertension.   Photo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... the receipt of a complete response letter, Actavis ...
(Date:12/24/2014)... /PRNewswire/  -- Tianyin Pharmaceutical Inc. (NYSE Amex: ... in the patented biopharmaceutical, modernized traditional Chinese medicine ... released unaudited preliminary financial results for the first ... Year 2015 Ended September 30, 2014 Financial Highlights: ... $14.7 million in 1Q14 with gross margins improved ...
(Date:12/24/2014)... Dec. 24, 2014 Soligenix, Inc. (OTCQB: ... company developing products that address unmet medical needs ... announced today that on December 24, 2014 it ... The Company raised approximately $2.3 million in ... use the net proceeds from the offering to ...
Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3
... Jan. 10, 2011 Ascension Orthopedics, Inc., a market ... a European patent for a PyroCarbon humeral head design ... Modular Shoulder System released in September 2010. ... of Ascension Orthopedics, commented, "I am very pleased our ...
... Inc. (Nasdaq: RDEA ) today announced that ... Bayer HealthCare AG (Bayer) under the terms of their ... Ardea,s mitogen-activated ERK kinase (MEK) inhibitor compounds for cancer ... initiation of a Phase 2 clinical study evaluating BAY ...
Cached Medicine Technology:Ascension Orthopedics Granted Patent for PyroCarbon Humeral Head Design 2Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing Collaboration 2Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing Collaboration 3
... Managing diabetes requires making decisions about insulin ... exercise. These decisions are guided by data ... information, and by the patterns that can ... Care Providers when the data is presented ...
... The Worlds First Solid-State Three-Color ... chosen to purchase over 3,000 Lumenis ... a busy practice, the Novus Varia ... lasers into a single, compact system ...
... Solid-State Three-Color Photocoagulator.,Retinal physicians throughout the ... 3,000 Lumenis multi-color photocoagulators.,For the retinal ... Novus Varia integrates green, yellow, and ... compact system that supports your treatment ...
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction....
Medicine Products: